Elizabeth Pattie is a Research Associate in the Imaging Development Group and joined the Lieber Institute in the summer of 2018. Her research applies molecular biology and cellular imaging techniques to characterize iPSC-derived neurons from schizophrenic and control patients. She graduated from Rochester Institute of Technology with a B.S. in Biotechnology and Molecular Bioscience. As an undergraduate, she was honored as a Research Scholar for her research on targeted molecular imaging agents and their binding affinity and uptake in 2D and 3D cellular models as potential diagnostic tools for prostate and breast cancers.